Roslyn Thibodeaux Goodall selected as a board member for the Alzheimer’s Association

Roslyn Goodall

Roslyn Goodall

DALLAS —Celebrating its 30th year, the Alzheimer’s Association, Greater Dallas Chapter is starting a new fiscal season with strong financials and new Board members to further amplify its mission to provide care and support for North Texans living with Alzheimer’s disease, and accelerate research to find a cure.

The new Board members include physicians, lawyers, entrepreneurs, executives and political advocates— all who have been affected by Alzheimer’s disease— and they bring their personal skills and abilities to the table with one common goal; to end Alzheimer’s disease.

Matt Johnson- Chairman of the Board

Founder and Managing Partner, Cedar Elm

Kathy Clements, Chair Communications Committee

Senior Vice President of Television Operations, Belo Corp

Roslyn Thibodeaux Goodall, Chair Public Policy Committee

UT Southwestern Hospital- Retired

Alzheimer’s Ambassador to Rep. Eddie Bernice Johnson

Diana Kerwin, M.D., Chair Programs & Services Committee

Director, Texas Alzheimer’s and Memory Disorders

Chief of Geriatrics, Texas Health Presbyterian Hospital Dallas

Robert Tobey, Chair Development Committee

Johnston Tobey, P.C.

Stephen Woodfin- Board Member, Communications Committee

Stephen Woodfin Attorney at Law

“We are excited about our new board members and will benefit from the diverse backgrounds represented on our Board,” said Matt Johnson, Chairman of the Board. “Placing professionals of this caliber in positions where they can use their expertise has raised the level of service from the Alzheimer’s Association.”

Johnson also said that the Association has launched a new dashboard allowing the public to track the Association’s work through the number of funds raised and people helped. Raising an excess of $450,000 the 2013 Dallas Walk to End Alzheimer’s more than doubled compared to last year.

More than 340,000 Texans are living with Alzheimer’s disease and there are over a million caregivers in the state. Alzheimer’s has no prevention, cure or even treatment to slow the disease. By the year 2050, one in three seniors are expected to have Alzheimer’s disease. The Alzheimer’s Association Board of Directors is working to get ahead of those numbers and help beat this disease before the numbers reach catastrophic proportions.

Carmina Barnett Footerboard Ad